PolyMedix developing novel oral mucositis drug
PMX-30063, a drug being developed by PolyMedix for the treatment of acute care conditions, has shown potential as a topical treatment for oral mucositis in
PMX-30063, a drug being developed by PolyMedix for the treatment of acute care conditions, has shown potential as a topical treatment for oral mucositis in
Patients with head and neck cancer (HNC) may be at risk for significant late effects after treatment, but they’re unlikely to discuss it with their
The same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs
Quest Diagnostics has developed a new molecular test panel designed to help clinicians determine if a thyroid gland is cancerous and requires surgical removal. The
Suicide rates among patients with oral cavity and oropharyngeal (OC/OP) cancer have increased significantly over the past three decades, particularly among male patients during the
Pacific Dental Services has agreed to purchase 400 of LED Dental’s VELscope Vx systems over three years. The handheld devices are used to detect early-stage
Air Techniques is sponsoring the First Annual Northern Illinois Oral Cancer Awareness Walk. The event will take place June 10, 8 a.m. through 1 p.m.
Swallowing function appears to return to acceptable levels in the long-term for patients who undergo surgical removal of tongue cancer lesions, according to a study
Scientists from The Scripps Research Institute have been awarded a five-year, $8.4 million grant from the National Institute on Drug Abuse of the National Institutes
StarDental has introduced plastic barriers for its Identafi oral cancer screening device to improve infection control. The disposable barriers, specifically designed for the Identafi, eliminate
The large U.S. tobacco tax increase implemented in April 2009 reduced the number of youth smokers by at least 220,000 and the number of youth
LED Medical Diagnostics, the Canadian manufacturer of the VELscope oral-cancer detection device, reported revenues of $1.8 million (US$1.78 million) for the first quarter of 2012